Literature DB >> 30786179

Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care.

John Lauriello1, Diana O Perkins2.   

Abstract

Schizophrenia is a chronic disorder that can be effectively controlled but will likely require lifelong treatment. Unfortunately, most patients experience numerous relapses, ongoing symptoms, and impairment, often because of treatment interruptions. Continuous treatment is imperative to prevent relapse and the potentially devastating consequences that can follow a return of psychotic symptoms. Clinicians must better monitor a common cause of relapse, nonadherence, and offer strategies to improve adherence. Strategies can target the patient, the environment, or treatment. One treatment-related strategy is the use of long-acting injectable (LAI) antipsychotics, which have the potential to reduce relapse and rehospitalization for many patients with schizophrenia. © Copyright 2019 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30786179     DOI: 10.4088/JCP.al18010ah2c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and Belgium.

Authors:  Rui Cai; Flore Decuypere; Pierre Chevalier; Martin Desseilles; Martin Lambert; Eric Fakra; Antonie Wimmer; Pascal Guillon; Stefan Pype; Annabelle Godet; Valeria Borgmeier
Journal:  BMC Psychiatry       Date:  2022-06-07       Impact factor: 4.144

2.  Attenuation of Olanzapine-Induced Endoplasmic Reticulum Stress Improves Insulin Secretion in Pancreatic Beta Cells.

Authors:  Diana Grajales; Patricia Vázquez; Rosa Alén; Ana B Hitos; Ángela M Valverde
Journal:  Metabolites       Date:  2022-05-16

3.  Discontinuity of psychiatric care for patients with schizophrenia, relation to previous psychiatric care and practice variation between providers: a retrospective longitudinal cohort study.

Authors:  Arnold P M van der Lee; Adriaan Hoogendoorn; Lieuwe de Haan; Aartjan T F Beekman
Journal:  BMC Psychiatry       Date:  2021-06-29       Impact factor: 3.630

Review 4.  Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain.

Authors:  Diana Grajales; Vitor Ferreira; Ángela M Valverde
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

5.  Mental Health Nurses' Tacit Knowledge of Strategies for Improving Medication Adherence for Schizophrenia: A Qualitative Study.

Authors:  Yao-Yu Lin; Wen-Jiuan Yen; Wen-Li Hou; Wei-Chou Liao; Mei-Ling Lin
Journal:  Healthcare (Basel)       Date:  2022-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.